Brief: Hansa Biopharma Partners With Cradle To Advance AI-Driven Protein Design And Engineering
01/10/2026 07:02
BRIEF-Hansa Biopharma Partners With Cradle To Advance AI-Driven Protein Design And Engineering Oct 1 (Reuters) - Hansa Biopharma AB HNSA.ST:
HANSA BIOPHARMA PARTNERS WITH CRADLE TO ADVANCE AI-DRIVEN PROTEIN DESIGN AND ENGINEERING
Source text: ID:nWkr4zxpXg
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS